GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quratis Inc (XKRX:348080) » Definitions » EV-to-EBIT

Quratis (XKRX:348080) EV-to-EBIT : -4.89 (As of Jun. 16, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Quratis EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Quratis's Enterprise Value is ₩63,911.6 Mil. Quratis's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-13,069.3 Mil. Therefore, Quratis's EV-to-EBIT for today is -4.89.

The historical rank and industry rank for Quratis's EV-to-EBIT or its related term are showing as below:

XKRX:348080' s EV-to-EBIT Range Over the Past 10 Years
Min: -7.26   Med: -4.8   Max: -2.63
Current: -5.06

During the past 6 years, the highest EV-to-EBIT of Quratis was -2.63. The lowest was -7.26. And the median was -4.80.

XKRX:348080's EV-to-EBIT is ranked worse than
100% of 422 companies
in the Biotechnology industry
Industry Median: 9.705 vs XKRX:348080: -5.06

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Quratis's Enterprise Value for the quarter that ended in Mar. 2024 was ₩93,670.9 Mil. Quratis's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-13,069.3 Mil. Quratis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -13.95%.


Quratis EV-to-EBIT Historical Data

The historical data trend for Quratis's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quratis EV-to-EBIT Chart

Quratis Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - - - -7.41

Quratis Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -3.98 -4.53 -7.41 -7.17

Competitive Comparison of Quratis's EV-to-EBIT

For the Biotechnology subindustry, Quratis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quratis's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quratis's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Quratis's EV-to-EBIT falls into.



Quratis EV-to-EBIT Calculation

Quratis's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=63911.647/-13069.287
=-4.89

Quratis's current Enterprise Value is ₩63,911.6 Mil.
Quratis's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-13,069.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quratis  (XKRX:348080) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Quratis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-13069.287/93670.947
=-13.95 %

Quratis's Enterprise Value for the quarter that ended in Mar. 2024 was ₩93,670.9 Mil.
Quratis's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-13,069.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quratis EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Quratis's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Quratis (XKRX:348080) Business Description

Traded in Other Exchanges
N/A
Address
306, 13, Teheran-ro 64-gil, Gangnam-gu, Seoul, KOR
Quratis Inc operates as a developer of vaccines and therapies designed to treat tuberculosis. The company develops youth and adults tuberculosis vaccines, messenger ribonucleic acids, and other related immune-related vaccines.

Quratis (XKRX:348080) Headlines

No Headlines